CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information...

Published on 26 Dec 2024 on Zacks · via Yahoo Finance

In the latest market close, CRISPR Therapeutics AG (CRSP) reached $41.07, with a +0.32% movement...

Read the rest of the article

Start tracking your investments with Statfolio

The most recent trading session ended with CRISPR Therapeutics AG (CRSP) standing at $39.36,...

Zacks · via Yahoo Finance 31 Dec 2024

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are goi...

Insider Monkey · via Yahoo Finance 31 Dec 2024

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article,...

Insider Monkey · via Yahoo Finance 29 Dec 2024

On Thursday, Cathie Wood-led Ark Invest made significant trades involving Palantir Technologies I...

Benzinga 27 Dec 2024

In the latest market close, CRISPR Therapeutics AG (CRSP) reached $41.07, with a +0.32% movement...

Zacks · via Yahoo Finance 26 Dec 2024

A day before Christmas, on Tuesday, Cathie Wood-led Ark Invest made significant adjustments to it...

Benzinga 25 Dec 2024

We can see that institutions own the lion's share in the company with 73% ownership. Put another...

Simply Wall St. · via Yahoo Finance 25 Dec 2024

We recommend five small and mid-sized Genomics & Synthetic Biology stocks with a favorable Zacks...

Zacks · via Yahoo Finance 23 Dec 2024

CRISPR Therapeutics' SWOT analysis: gene editing pioneer's stock faces pivotal year

Investing.com 21 Dec 2024

We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this...

Insider Monkey · via Yahoo Finance 11 Dec 2024